CAS: 67-62-9; O-Methylhydroxylamine

该化合物是氢氧基胺的甲基衍生物,通常用作有机合成和制药应用的多种用途中间体,其主要优点包括它作为氢氧基胺的保护群体的作用及其在核生殖反应中的活性.该化合物的甲基替代可增强稳定性,而相对于非代用氢氧基胺而言,它更适合某些合成途径.它也被用于制造氧化醚和其他具有功能的含氮化合物.对于受控反应而言,由于对水分和氧化的敏感性,O-甲基氧基胺通常在惰性条件下处理.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号593-56-6 甲氧胺盐酸盐 | CAS号1914-20-1 N-甲氧基邻苯二甲酰亚胺 | CAS号103621-63-2 3-(methoxyamino... | CAS号622-33-3 邻苄基羟胺 | CAS号13858-85-0 Cyclohexanone O... | CAS号67-56-1 甲醇 | CAS号3376-33-8 (Z)-N-methoxy-1... | CAS号3376-32-7 N-Benzylidene-O... | CAS号72278-08-1 o-methyl 4-meth... | CAS号107496-42-4 3-(1-Methoxyimi... | CAS号3871-28-1 N-甲氧基氨基甲酸乙酯 | CAS号593-56-6 甲氧胺盐酸盐 | CAS号93-89-0 苯甲酸乙酯 | CAS号4424-16-2 O-methyl-benzam... | CAS号100-46-9 苄胺 | CAS号14898-71-6 Phosphoramidicd... | CAS号143076-07-7 4-chloro-N-meth... | CAS号462-94-2 1,5-二氨基戊烷 | CAS号50548-43-1 二苯并[b,d]呋喃-4-胺

合成工艺路线路线简述

    📜甲氧基胺盐酸盐置于sodium Hydroxide体系中,用72%的收率获得产物3-氯苯甲酰乙腈
    参考文献:细胞色素p450一氧化氮还原酶关键中间体的合成模型复合物
    标题:细胞色素p450一氧化氮还原酶关键中间体的合成模型复合物
    摘要:真菌反硝化在氮循环中起着关键作用,并有助于农业土壤中的总n 2 O排放.在此,细胞色素p450还原酶no(p450Nor)降低2 No至n 2使用单个血红素部位o.尽管进行了大量研究,但负责p450Nor中关键n-n偶联步骤的关键"中间体i"的确切性质尚不清楚.该物质可能对应于具有未知电子结构的fe-Nhoh型中间体.这里,我们报告了新的策略,以产生一个模型系统,用于该中间,从铁(iii)开始methylhydroxylamide复杂的[fe(3,5-Me-Bafp)(nhome)](1),将其充分表征通过1H NMR,Uv-Vis,电子顺磁共振和振动光谱法(rraman和nrvs).我们的数据表明1是具有强配位作用的n结合羟酰胺配体的高纺铁络合物(fe-N距离为1.918å; Fe-Nhome拉伸为558 Cm-1).然后在-80oc进行简单的单电子氧化1,然后干净地反应生成中间体i
    DOI:10.1021/acs.Inorgchem.8B02947

    海关参考信息

    专利信息


    专利号:US-8822702-B2
    优先权日:2002-12-20
    标 题 :Synthesis of amines and intermediates for the synthesis thereof
    发明人:BERENS ULRICH; DOSENBACH OLIVER; SPRENGER DANIEL
    权利人:BERENS ULRICH; DOSENBACH OLIVER; SPRENGER DANIEL; BASF SE
    摘要:The invention relates in a first embodiment to a method for the manufacture of esters of the formula I, n nor especially of amides of the formula II,n n nwherein the symbols have the meanings given in the specification, as well as other intermediates and compounds useful in the synthesis of tryptamines and other substances mentioned in the title. The synthesis methods and intermediates are useful in the synthesis of pharmaceuticals.

    专利号:US-5977301-A
    优先权日:1992-09-24
    标题 :Synthesis of N-substituted oligomers
    发明人:ZUCKERMAN RONALD N; KERR JANICE M; KENT STEPHEN B H; MOOS WALTER H; SIMON REYNA J; GOFF DANE A
    权利人:CHIRON CORP
    摘要:A solid-phase method for the synthesis of N-substituted oligomers, such as poly (N-substituted glycines) (referred to herein as poly NSGs) is used to obtain oligomers, such as poly NSGs of potential therapeutic interest which poly NSGs can have a wide variety of side-chain substituents. Each N-substituted glycine monomer is assembled from two 'sub-monomers' directly on the solid support. Each cycle of monomer addition consists of two steps: (1) acylation of a secondary amine bound to the support with an acylating agent comprising a leaving group capable of nucleophilic displacement by -NH2, such as a haloacetic acid, and (2) introduction of the side-chain by nucleophilic displacement of the leaving group, such as halogen (as a resin-bound alpha -haloacetamide) with a sufficient amount of a second sub-monomer comprising an -NH2 group, such as a primary amine, alkoxyamine, semicarbazide, acyl hydrazide, carbazate or the like. Repetition of the two step cycle of acylation and displacement gives the desired oligomers. The efficient synthesis of a wide variety of oligomeric NSGs using automated synthesis technology of the present method makes these oligomers attractive candidates for the generation and rapid screening of diverse peptidomimetic libraries. The oligomers of the invention, such as N-substituted glycines (i.e. poly NSGs) disclosed here provide a new class of peptide-like compounds not found in nature, but which are synthetically accessible and have been shown to possess significant biological activity and proteolytic stability.

    专利号:EP-0671928-B1
    优先权日:1992-09-24
    标题 :Synthesis of n-substituted oligomers
    发明人:ZUCKERMANN RONALD N; KERR JANICE M; KENT STEPHEN BRIAN HENRY; MOOS WALTER H; SIMON REYNA J; GOFF DANE A
    权利人:CHIRON CORP
    摘要:Poly N-substituted Glycines (poly NSGs), wherein the substituents bear purine or pyrimidine bases (R<9>) every second glycine: In addition, a solid phase method for the synthesis of N-substituted oligomers of more general structures is disclosed.The poly NSGs obtainable by this method can have a wide variety of side-chain substituents. Each N-substituted glycine monomer is assembled from two 'sub-monomers' directly on the solid support. Each cycle of monomer addition consists of two steps: (1) acylation of a secondary amine bound to the support with an acylating agent comprising a leaving group capable of nucleophilic displacement by -NH2, such as a haloacetic acid, and (2) introduction of the side-chain by nucleophilic displacement of the leaving group, such as halogen (as a resin-bound alpha -haloacetamide) with a sufficient amount of a second sub-monomer comprising an -NH2 group, such as a primary amine, alkoxyamine, semicarbazide, acyl hydrazide, carbazate or the like. Repetition of the two step cycle of acylation and displacement gives the desired oligomers. The efficient synthesis of a wide variety of oligomeric NSGs using the automated synthesis technology of the present method makes these oligomers attractive candidates for the generation and rapid screening of diverse peptidomimetic libraries. The oligomers of the invention, such as N-substituted glycines (i.e. poly NSGs) disclosed here provide a new class of peptide-like compounds not found in nature, but which are synthetically accessible and have been shown to possess significant biological activity and proteolytic stability.

    专利号:US-5877278-A
    优先权日:1992-09-24
    标题:Synthesis of N-substituted oligomers
    发明人:ZUCKERMANN RONALD N; GOFF DANE A; NG SIMON; SPEAR KERRY; SCOTT BARBARA O; SIGMUND AARON C; GOLDSMITH RICHARD A; MARLOWE CHARLES K; PEI YAZHONG; RICHTER LUTZ; SIMON REYNA
    权利人:CHIRON CORP
    摘要:A solid-phase method for the synthesis of N-substituted oligomers, such as poly (N-substituted glycines) (referred to herein as poly NSGs) is used to obtain oligomers, such as poly NSGs of potential therapeutic interest which poly NSGs can have a wide variety of side-chain substituents. Each N-substituted glycine monomer is assembled from two 'sub-monomers' directly on the solid support. Each cycle of monomer addition consists of two steps: (1) acylation of a secondary amine bound to the support with an acylating agent comprising a leaving group capable of nucleophilic displacement by -NH2, such as a haloacetic acid, and (2) introduction of the side-chain by nucleophilic displacement of the leaving group, such as halogen (as a solid support-bound alpha -haloacetamide) with a sufficient amount of a second sub-monomer comprising an -NH2 group, such as a primary amine, alkoxyamine, semicarbazide, acyl hydrazide, carbazate or the like. Repetition of the two step cycle of acylation and displacement gives the desired oligomers. The efficient synthesis of a wide variety of oligomeric NSGs using automated synthesis technology of the present method makes these oligomers attractive candidates for the generation and rapid screening of diverse peptidomimetic libraries. The oligomers of the invention, such as N-substituted glycines (i.e. poly NSGs) disclosed here provide a new class of peptide-like compounds not found in nature, but which are synthetically accessible and have been shown to possess significant biological activity and proteolytic stability. Combinatorial libraries of cyclic compounds are disclosed wherein the cyclic compounds are comprised of at least one ring structure derived from cyclization of a peptoid backbone. The diversity of product compounds is generated by the sequential addition of substituted submonomers. The combinatorial library includes 10 or more, preferably 100 or more, and more preferably 1,000 or more distinct and different compounds. The library includes each of the product compounds in retrievable and analyzable amounts and preferably includes at least one biologically active compound. Methods of synthesizing the combinatorial libraries and assay devices produced using the libraries are disclosed as is methodology for screening for and obtaining biologically active cyclic organic compounds.

    专利号:US-9469614-B2
    优先权日:2011-10-27
    标 题:Synthesis of triazolopyrimidine compounds
    发明人:ZUPANCIC BORUT; MARAS NENAD; STERK DAMJAN
    权利人:LEK PHARMACEUTICALS
    摘要:The present invention relates to the field of organic synthesis and describes the synthesis of specific triazolopyrimidine compounds and intermediates thereof as well as related derivatives.

    专利号:US-7678877-B2
    优先权日:2004-12-03
    标题 :Process for the synthesis of polyalkylphenol antioxidants
    发明人:YANG SUIZHOU; CHOLLI ASHOK L
    权利人:POLNOX CORP
    摘要:Disclosed is a method for the synthesis of sterically hindered polymeric antioxidants based on phenol type antioxidant monomers. The method includes partially etherifying, polymerizing and thermally rearranging a phenol containing monomer represented by the following structural formula: n nto produce a sterically hindered polymeric macromolecular antioxidant. X, R 10 and q are as defined herein. The disclosed method is a simple, direct and economical process for the synthesis of sterically hindered polymeric macromolecular antioxidants.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1021/bi200675y
    摘要:Piechnick R, Heck M, Sommer ME. Alkylated hydroxylamine derivatives eliminate peripheral retinylidene Schiff bases but cannot enter the retinal binding pocket of light-activated rhodopsin. Biochemistry. 2011 Aug 23;50(33):7168–76. doi: 10.1021/bi200675y.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知